[Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].

A multicentre open therapeutic trial comparing carbamazepine with slow-release carbamazepine was conducted in 114 epileptic patients older than 12 years. The patients received the two products successively during two periods of 1 month each. With slow-release carbamazepine the number of doses could be reduced to 2 per day without decrease in effectiveness and with less side-effects. The twice-a-day dosage should result in better compliance and consequently in a better quality of treatment in the long term.